Hugh M. Cole, Chief Business Officer at Jounce Therapeutics, Inc. (JNCE), sold 6,219 shares at $7.00 ($43K) on 2021-01-08, disclosed to the SEC on 2021-01-11.
Open-market sale of $43k JNCE by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.76 | 2,879 | $19K | 45.4% |
| 2 | $7.00 | 3,340 | $23K | 54.6% |
| Total | $6.89 avg | 6,219 | $43K | 100% |
| Filing → |
| JNCE | SELL | 2021-01-25 | $215K | — | Filing → |
| JNCE | SELL | 2020-08-18 | $10K | — | Filing → |
| JNCE | SELL | 2020-01-10 | $20K | — | Filing → |